About: Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2.

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 June 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в червні 2013 (uk) مقالة علمية نشرت في 05 يونيو 2013 (ar) scientific article published on 05 June 2013 (en)
publication date	wds:Q37465472-BAC1B3AA-7E80-4204-9C9A-A675555D8A3B
publication date	2013-06-05 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37465472-EE6DE5FD-137F-4AE3-9265-257EE4865F87
language of work or name	English
cites work	wds:Q37465472-05092B5C-42FC-4C9B-A4C2-561E28C856C1 wds:Q37465472-07FD5DE4-3BCB-4AE7-8032-A8EF70F0FF9A wds:Q37465472-13DFE99F-EBA1-4A85-B10A-583EB4DD6437 wds:Q37465472-23CFDCD2-5FE3-42E7-A065-7F850AB36E38 wds:Q37465472-319EE084-0303-4037-879E-A4BBB94154F2 wds:Q37465472-340A2540-FC6C-40A0-8F27-2652F0FB4A52 wds:Q37465472-45A7B60C-2775-4EB2-B303-625C6A3ABC21 wds:Q37465472-54E9239B-503F-424B-AED7-AA78E93F5462 wds:Q37465472-5FF03DBD-ED25-4068-9F64-65692694AE9E wds:Q37465472-6D2868E7-A547-4599-90AE-34FA502C0195 wds:Q37465472-6E7EB767-A1E5-4AA1-AE97-D4180CDCA49B wds:Q37465472-B184062D-6004-421E-8853-82C612C43464 wds:Q37465472-B7A810C8-8BFD-4822-838C-C0CDAFC969E9 wds:Q37465472-CDCE9D1E-7133-4256-9304-79F169B1DFEE wds:Q37465472-E6C28849-1548-4580-BE37-825831E1E34D wds:Q37465472-F153DCDD-E8EA-46E3-933A-7006F097B016
cites work	Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis Discontinuing treatment in patients with rheumatoid arthritis in sustained clinical remission: exploratory analyses from the BeSt study Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1 Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial Frequency and duration of drug-free remission after 1 year of treatment with etanercept versus sulfasalazine in early axial spondyloarthritis: 2 year data of the ESTHER trial Efficacy of adalimumab in the treatment of axial spondylarthritis without radiographically defined sacroiliitis: results of a twelve-week randomized, double-blind, placebo-controlled trial followed by an open-label extension up to week fifty-two The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1). Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab Clinical and imaging efficacy of infliximab in HLA-B27-Positive patients with magnetic resonance imaging-determined early sacroiliitis
author name string	wds:Q37465472-172CE0E6-9B21-4718-8417-E19E25885F6C wds:Q37465472-1D7FFCA3-207B-43CF-A34F-8B69A46C1259 wds:Q37465472-2187029A-29ED-45B5-AE5D-F1A968CF1D43 wds:Q37465472-2D852520-775D-4207-8DBD-D500414FE11C wds:Q37465472-3FF4EAA6-20B3-4029-9C20-0919B560804E wds:Q37465472-4350501C-27F1-4492-97D1-89DFE64966FF wds:Q37465472-74177EE4-552B-4F4E-87C9-FE67F44E3FF4 wds:Q37465472-7DBA4682-B010-436A-B25D-177FDBE3411E wds:Q37465472-A3CACE0F-75B7-4352-9E09-CF0E30E0817B wds:Q37465472-A64C45D7-5DB1-47A8-9D19-FC774C046D0E wds:Q37465472-AEEBF05F-B0BD-40FA-B643-14DB68FDDA29
author name string	S Park R Yao Y Song J Sieper J Wollenhaupt N Vastesaeger M Rudwaleit J Lenaerts D Chitkara All INFAST Investigators L Myasoutova
rdfs:label	Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (en) Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (nl) Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (ast)
skos:prefLabel	Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (en) Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (nl) Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (ast)
name	Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (en) Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (nl) Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2. (ast)
author	wds:Q37465472-420E4087-672C-4A35-AEFE-CE8083F6BFE5
author	Vadim Mazurov
title	wds:Q37465472-16389087-4E82-469C-8CC4-5FDBBBBF1DBC
title	Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2 (en)
page(s)	wds:Q37465472-CB5747F5-577F-4029-81FF-3C235D1AE6A9
page(s)	108-113
instance of	wds:Q37465472-1E4FE350-8DE3-4EA4-9673-AB853BED07B9
instance of	scholarly article
main subject	wds:Q37465472-8CE1F230-9F7A-400B-B918-C480033368E0
main subject	wd:Q1215575
PubMed ID	wds:Q37465472-80240F9D-B822-41CE-9BB6-55C5BEACEA9F
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23740231
PubMed ID	23740231
published in	wds:Q37465472-3F5A31B8-0053-46D8-A762-C745C75F82C9
published in	Annals of the Rheumatic Diseases
issue	wds:Q37465472-C37CFD10-B899-4B70-8360-AE4039050B69

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software